Toast: Jefferies Raises Buy Rating to $54, Ups PT from $50
ByAinvest
Friday, Jul 18, 2025 11:08 am ET1min read
PIPR--
Toast Inc. reported a notable 26.72% revenue growth over the past year, with its stock hitting a new 52-week high of $46.98, reflecting a significant upward trajectory [2]. The company's valuation has reached $26.09 billion, underscoring investor confidence in its robust performance and growth prospects [2].
Several analysts have also raised their price targets for Toast Inc. BMO Capital Markets raised its target to $45, Piper Sandler to $37, and Keefe, Bruyette & Woods to $42, citing strong execution, increased full-year 2025 guidance, and success in securing enterprise clients [2].
Jefferies analysts noted that Toast Inc.'s strong annual recurring revenue growth and expansion into Enterprise locations are key drivers behind the positive sentiment surrounding the company's stock [2]. The firm's ability to navigate market conditions effectively and secure enterprise-level contracts has been highlighted by multiple analysts [2].
While the stock's high P/E ratio of 173.8x indicates a premium valuation, the company's strong financial health and positive outlook have led Jefferies to maintain a "Buy" rating with an increased price target [2].
References:
[1] https://finance.yahoo.com/news/jefferies-raises-cogent-biosciences-cogt-162331043.html
[2] https://ca.investing.com/news/company-news/toast-inc-stock-hits-52week-high-at-4698-usd-93CH-4106380
TOST--
Toast: Jefferies Raises Buy Rating to $54, Ups PT from $50
Jefferies, a leading financial research firm, has upgraded its rating for Toast Inc. (NYSE: TOST) to "Buy" and increased its price target to $54 from $50. This decision comes on the heels of the company's strong first-quarter results, which exceeded market expectations [2].Toast Inc. reported a notable 26.72% revenue growth over the past year, with its stock hitting a new 52-week high of $46.98, reflecting a significant upward trajectory [2]. The company's valuation has reached $26.09 billion, underscoring investor confidence in its robust performance and growth prospects [2].
Several analysts have also raised their price targets for Toast Inc. BMO Capital Markets raised its target to $45, Piper Sandler to $37, and Keefe, Bruyette & Woods to $42, citing strong execution, increased full-year 2025 guidance, and success in securing enterprise clients [2].
Jefferies analysts noted that Toast Inc.'s strong annual recurring revenue growth and expansion into Enterprise locations are key drivers behind the positive sentiment surrounding the company's stock [2]. The firm's ability to navigate market conditions effectively and secure enterprise-level contracts has been highlighted by multiple analysts [2].
While the stock's high P/E ratio of 173.8x indicates a premium valuation, the company's strong financial health and positive outlook have led Jefferies to maintain a "Buy" rating with an increased price target [2].
References:
[1] https://finance.yahoo.com/news/jefferies-raises-cogent-biosciences-cogt-162331043.html
[2] https://ca.investing.com/news/company-news/toast-inc-stock-hits-52week-high-at-4698-usd-93CH-4106380

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet